Johnson & Johnson cut its yearly revenue projection as pharmaceutical sales missedouton expectations and suspended its assistance for Covid-19 vaccine sales duetothefactthat of uncertain need and worldwide supply surplus.
Read More.
The news from the world
The news from the world